Z19 Hormone sensitivity malignancy status
Z19 is the ICD-10-CM code family for Hormone sensitivity malignancy status: 2 codes, none of which can lead a home health claim.
Codes in family
2
Can lead a claim
0
Cannot lead a claim
2
What CMS assigns to Z19
None of the 2 codes is assigned a clinical group. None of the 2 is assigned a comorbidity subgroup. None can lead a claim. CMS attaches a code-first note to all 2.
Code first
CMS grouper convention 12, on all 2 codes. Code first:
- underlying disease
Every code in Z19
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| Z19.1 | Hormone sensitive malignancy status | Cannot lead a claimUnacceptable principal diagnosis, code is not reportable as principal diagnosis | None | None |
| Z19.2 | Hormone resistant malignancy status | Cannot lead a claimUnacceptable principal diagnosis, code is not reportable as principal diagnosis | None | None |
Sources: CMS HH PPS Grouper Software (opens in a new tab) v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 (opens in a new tab) code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.